These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 6093527)

  • 41. [Effect of cefotaxime on hemostasis].
    Kamiya T; Saito H; Sakuragawa N; Imaoka S; Kuramoto A
    Jpn J Antibiot; 1987 Jul; 40(7):1275-93. PubMed ID: 3682182
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is Ciprofloxacin in Combination With Beta-lactam Antibiotics a Recipe for Thrombocytosis?: A Case Report of Thrombocytosis in a Patient Receiving Ciprofloxacin and Ceftriaxone.
    Onor I; Andonie G; Hoang L; Smith T; Guillory S; Walvekar S; Sanne S
    P T; 2019 Dec; 44(12):749-753. PubMed ID: 33935476
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ceftriaxone. A pharmacoeconomic evaluation of its use in the treatment of serious infections.
    Davis R; Bryson HM
    Pharmacoeconomics; 1994 Sep; 6(3):249-69. PubMed ID: 10155268
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ceftriaxone. A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration.
    Brogden RN; Ward A
    Drugs; 1988 Jun; 35(6):604-45. PubMed ID: 3048974
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical pharmacokinetics of ceftriaxone.
    Yuk JH; Nightingale CH; Quintiliani R
    Clin Pharmacokinet; 1989 Oct; 17(4):223-35. PubMed ID: 2686882
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ceftriaxone in the treatment of meningitis, gonococcal infections and other serious bacterial infections. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
    CMAJ; 1990 Mar; 142(5):450-2. PubMed ID: 2302641
    [No Abstract]   [Full Text] [Related]  

  • 47. Clinical adverse effects during ceftriaxone therapy.
    Moskovitz BL
    Am J Med; 1984 Oct; 77(4C):84-8. PubMed ID: 6093526
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical and bacteriologic efficacy of ceftriaxone in the United States.
    McCloskey RV
    Am J Med; 1984 Oct; 77(4C):97-103. PubMed ID: 6093528
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ceftriaxone treatment of skin and soft tissue infections in a once daily regimen.
    Bradsher RW; Snow RM
    Am J Med; 1984 Oct; 77(4C):63-7. PubMed ID: 6093522
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ceftriaxone therapy of meningitis and serious infections.
    Steele RW
    Am J Med; 1984 Oct; 77(4C):50-3. PubMed ID: 6093519
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Abnormal laboratory test values during ceftriaxone therapy.
    Oakes M; MacDonald H; Wilson D
    Am J Med; 1984 Oct; 77(4C):89-96. PubMed ID: 6093527
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetic profile of ceftriaxone in man.
    Patel IH; Kaplan SA
    Am J Med; 1984 Oct; 77(4C):17-25. PubMed ID: 6093513
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.